Reversal of Diabetes Insipidus in Brattleboro Rats: Intrahypothalamic Injection of Vasopressin mRNA

Characterization of oligonucleotide transport into living cells.

Loke, S. L., Stein, C. A., Zhang, X. H., Mori, K., Nakanishi, M., Subasinghe, C., Cohen, J. S., & Neckers, L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3474 · Cited by 734 · see citing works

Single base deletion in the vasopressin gene is the cause of diabetes insipidus in Brattleboro rats

Schmale, H., & Richter, D. (1984) · Nature · doi:10.1038/308705a0 · Cited by 405 · see citing works

Parsimony Analysis in Historical Biogeography and Coevolution: Methodological and Theoretical Update

Brooks, D. R. (1990) · Systematic Zoology · doi:10.2307/2992205 · Cited by 264 · see citing works

Tissue-specific expression of mouse α-amylase genes

Schibler, U., Tosi, M., Pittet, A.-C., Fabiani, L., & Wellauer, P. K. (1980) · Journal of Molecular Biology · doi:10.1016/0022-2836(80)90208-9 · Cited by 187 · see citing works

Axonal transport of neuropeptide encoding mRNAs within the hypothalamo‐hypophyseal tract of rats.

Mohr, E., Fehr, S., & Richter, D. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07781.x · Cited by 165 · see citing works

The Vasopressin mRNA Poly(A) Tract is Unusually Long and Increases during Stimulation of Vasopressin Gene Expression in Vivo

Carrazana, E. J., Pasieka, K. B., & Majzoub, J. A. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.6.2267-2274.1988 · Cited by 149 · see citing works

mRNA coding for oxytocin is present in axons of the hypothalamo-neurohypophysial tract.

Jirikowski, G. F., Sanna, P. P., & Bloom, F. E. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.19.7400 · Cited by 149 · see citing works

Vasopressin Gene Expression in the Rodent Hypothalamus: Transcriptional and Posttranscriptional Responses to Physiological Stimulation

Murphy, D., & Carter, D. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-7-1051 · Cited by 105 · see citing works

Regulation of poly(A) tail size of vasopressin mRNA.

Zingg, H. H., Lefebvre, D. L., & Almazán, G. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37914-6 · Cited by 96 · see citing works

Independent Regulation of Neuropeptide mRNA Level and Poly(A) Tail Length

Carter, D., & Murphy, D. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83468-8 · Cited by 89 · see citing works

Vasopressin RNA in the neural lobe of the pituitary: dramatic accumulation in response to salt loading.

Murphy, D., Levy, A., Lightman, S. L., & Carter, D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.9002 · Cited by 81 · see citing works

Detection of a secreted form of the murine H-2 class I antigen with an antibody against its predicted carboxyl terminus.

Maloy, W. L., Coligan, J. E., Barra, Y., & Jay, G. D. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.4.1216 · Cited by 72 · see citing works

Dendritic transport: quantitative analysis of the time course of somatodendritic transport of recently synthesized RNA

Davis, L. A., Burger, B., Banker, G., & Steward, O. (1990) · Journal of Neuroscience · doi:10.1523/jneurosci.10-09-03056.1990 · Cited by 64 · see citing works

Sex differences among oxytocin-immunoreactive neuronal systems in the mouse hypothalamus.

Hu, H., Gf, J., & Jd, C. (1990) · PubMed · Cited by 63 · see citing works

Presence of neuropeptide messenger RNAs in neuronal processes

Bloch, B., Guitteny, A. F., Normand, E., & Chouham, S. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90004-s · Cited by 38 · see citing works

The brain-specific gene 1B236 is expressed postnatally in the developing rat brain

Lenoir, D., Battenberg, E. L. F., Kiel, M., Bloom, F. E., & Milner, R. (1986) · Journal of Neuroscience · doi:10.1523/jneurosci.06-02-00522.1986 · Cited by 34 · see citing works

Application of a new intraventricular injection technique in rat brain norepinephrine studies

Popick, F. R. (1976) · Life Sciences · doi:10.1016/0024-3205(76)90025-4 · Cited by 32 · see citing works

The Origin and Regulation of Posterior Pituitary Vasopressin Ribonucleic Acid in Osmotically Stimulated Rats

Levy, A., Lightman, S. L., Carter, D., & Murphy, D. (1990) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1990.tb00413.x · Cited by 31 · see citing works

Vasopressin mRNA in the neurolobe of the rat pituitary

Lehmann, E., Hänze, J., Pauschinger, M., Ganten, D., & Lang, R. E. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90363-e · Cited by 25 · see citing works

Comparison of brain ribonucleases of rabbit, guinea pig, rat, mouse and gerbil

Schulz-Harder, B., & Keyserlingk, D. G. (1988) · Histochemistry · doi:10.1007/bf00570329 · Cited by 11 · see citing works

mRNA vaccines — a new era in vaccinology

Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667 · see citing works

Lipid nanoparticles for mRNA delivery

Hou, X., Zaks, T., Langer, R., & Dong, Y. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00358-0 · Cited by 4,076 · see citing works

mRNA-based therapeutics--developing a new class of drugs

Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474 · see citing works

Exploring treatment options in cancer: tumor treatment strategies

Liu, B., Zhou, H., Tan, L., Siu, K. T. H., & Guan, X.-Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01856-7 · Cited by 1,201 · see citing works

Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes

Pardi, N., Tuyishime, S., Muramatsu, H., Kariko, K., Mui, B. L., Tam, Y. K., Madden, T. D., Hope, M. J., & Weissman, D. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.007 · Cited by 1,014 · see citing works

Tools for translation: non-viral materials for therapeutic mRNA delivery

Hajj, K. A., & Whitehead, K. A. (2017) · Nature Reviews Materials · doi:10.1038/natrevmats.2017.56 · Cited by 799 · see citing works

Cancer vaccines as promising immuno-therapeutics: platforms and current progress

Liu, J., Fu, M., Wang, M., Wan, D., Wei, Y., & Wei, X. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01247-x · Cited by 725 · see citing works

The tangled history of mRNA vaccines

Dolgin, E. (2021) · Nature · doi:10.1038/d41586-021-02483-w · Cited by 556 · see citing works

The Limitless Future of RNA Therapeutics

Damase, T. R., Sukhovershin, R. A., Boada, C., Taraballi, F., Pettigrew, R. I., & Cooke, J. P. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.628137 · Cited by 549 · see citing works

Modulation of Anxiety and Neuropeptide Y-Y1 Receptors by Antisense Oligodeoxynucleotides

Wahlestedt, C., Pich, E. M., Koob, G. F., Yee, F., & Heilig, M. A. (1993) · Science · doi:10.1126/science.8380941 · Cited by 524 · see citing works

Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals

Thess, A., Grund, S., Mui, B. L., Hope, M. J., Baumhof, P., Fotin-Mleczek, M., & Schlake, T. (2015) · Molecular Therapy · doi:10.1038/mt.2015.103 · Cited by 513 · see citing works

A Comprehensive Review of mRNA Vaccines

Gote, V., Bolla, P. K., Kommineni, N., Butreddy, A., Nukala, P. K., Palakurthi, S. S., & Khan, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032700 · Cited by 457 · see citing works

A Comparison of Plasmid DNA and mRNA as Vaccine Technologies

Liu, M. A. (2019) · Vaccines · doi:10.3390/vaccines7020037 · Cited by 428 · see citing works

mRNA vaccine: a potential therapeutic strategy

Wang, Y., Zhang, Z., Luo, J., Han, X., Wei, Y., & Wei, X. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01311-z · Cited by 422 · see citing works

Gene Regulation in the Magnocellular Hypothalamo-Neurohypophysial System

Burbach, J. P. H., Luckman, S. M., Murphy, D., & Gainer, H. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.3.1197 · Cited by 338 · see citing works

mRNA vaccines for COVID-19: what, why and how

Park, J. W., Lagniton, P. N. P., Liu, Y., & Xu, R.-H. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59233 · Cited by 321 · see citing works

Systemic delivery of factor IX messenger RNA for protein replacement therapy

Ramaswamy, S., Tonnu, N., Tachikawa, K., Limphong, P., Vega, J. B., Karmali, P. P., Chivukula, P., & Verma, I. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1619653114 · Cited by 301 · see citing works

mRNA-based therapeutics: looking beyond COVID-19 vaccines

Parhiz, H., Atochina‐Vasserman, E. N., & Weissman, D. (2024) · The Lancet · doi:10.1016/s0140-6736(23)02444-3 · Cited by 296 · see citing works

Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietin

Karikó, K., Muramatsu, H., Keller, J. M., & Weissman, D. (2012) · Molecular Therapy · doi:10.1038/mt.2012.7 · Cited by 282 · see citing works

Behavioral Consequences of Intracerebral Vasopressin and Oxytocin: Focus on Learning and Memory **This paper is dedicated to our friend and scientific teacher Prof. Dr Armin Ermisch (1935–1995).

Engelmann, M., Wotjak, C. T., Neumann, I. D., Ludwig, M., & Landgraf, R. (1996) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(95)00059-3 · Cited by 267 · see citing works

mRNA vaccines in disease prevention and treatment

Zhang, G., Tang, T., Chen, Y., Huang, X., & Liang, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01579-1 · Cited by 253 · see citing works

Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications

Shi, Y., Shi, M., Wáng, Y., & You, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02002-z · Cited by 231 · see citing works

mRNA transcript therapy

Weissman, D. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.973859 · Cited by 228 · see citing works

Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives

Gómez-Aguado, I., Rodríguez-Castejón, J., Vicente-Pascual, M., Rodríguez‐Gascón, A., Solinís, M. Á., & del Pozo‐Rodríguez, A. (2020) · Nanomaterials · doi:10.3390/nano10020364 · Cited by 224 · see citing works

Antisense inhibition of AT1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin

Gyurko, R., Wielbo, D., & Phillips, M. I. (1993) · Regulatory Peptides · doi:10.1016/0167-0115(93)90438-e · Cited by 211 · see citing works

In Vitro Transcription of Long RNA Containing Modified Nucleosides

Pardi, N., Muramatsu, H., Weissman, D., & Karikó, K. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-260-5_2 · Cited by 204 · see citing works

Nucleic acid drugs: recent progress and future perspectives

Sun, X., Setrerrahmane, S., Li, C., Hu, J., & Xu, H. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02035-4 · Cited by 202 · see citing works

Role of Lipid-Based and Polymer-Based Non-Viral Vectors in Nucleic Acid Delivery for Next-Generation Gene Therapy

Wahane, A. V., Waghmode, A., Kapphahn, A., Dhuri, K., Gupta, A., & Bahal, R. (2020) · Molecules · doi:10.3390/molecules25122866 · Cited by 196 · see citing works

HPLC purification of in vitro transcribed long RNA

Weissman, D., Pardi, N., Muramatsu, H., & Karikó, K. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-260-5_3 · Cited by 180 · see citing works

Biocompatible, Purified VEGF-A mRNA Improves Cardiac Function after Intracardiac Injection 1 Week Post-myocardial Infarction in Swine

Carlsson, L. G., Clarke, J. C., Yen, C. Y. T., Gregoire, F. M., Albery, T., Billger, M. A., Egnell, A., Gan, L., Jennbacken, K., Johansson, E., et al. (2018) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2018.04.003 · Cited by 180 · see citing works

Effective mRNA pulmonary delivery by dry powder formulation of PEGylated synthetic KL4 peptide

Qiu, Y., Man, R. C. H., Liao, Q., Kung, K. L. K., Chow, M. Y. T., & Lam, J. K. W. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.10.026 · Cited by 178 · see citing works

Specific inhibition of endogenous neuropeptide Y synthesis in arcuate nucleus by antisense oligonucleotides suppresses feeding behavior and insulin secretion

Akabayashi, A., Wahlestedt, C., Alexander, J. T., & LEIBOWITZ, S. F. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90377-8 · Cited by 176 · see citing works

Current Advances in RNA Therapeutics for Human Diseases

Zogg, H., Singh, R., & Ro, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052736 · Cited by 173 · see citing works

mRNA mediates passive vaccination against infectious agents, toxins, and tumors

Thran, M., Mukherjee, J., Pönisch, M., Fiedler, K., Thess, A., Mui, B. L., Hope, M. J., Tam, Y. K., Horscroft, N., Heidenreich, R., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201707678 · Cited by 166 · see citing works

mRNA in the Context of Protein Replacement Therapy

Vavilis, T., Stamoula, Ε., Ainatzoglou, A., Sachinidis, A., Lamprinou, M., Dardalas, I., & Vizirianakis, I. S. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15010166 · Cited by 143 · see citing works

Exosome-mediated mRNA delivery in vivo is safe and can be used to induce SARS-CoV-2 immunity

Tsai, S. J., Atai, N. A., Cacciottolo, M., Nice, J., Salehi, A., Guo, C., Sedgwick, A., Kanagavelu, S., & Gould, S. J. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101266 · Cited by 142 · see citing works

Nanomedicine-Based Approaches for mRNA Delivery

Uchida, S., Perche, F., Pichon, C., & Cabral, H. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00618 · Cited by 139 · see citing works

mRNA as novel technology for passive immunotherapy

Schlake, T., Theß, A., Thran, M., & Jordan, I. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2935-4 · Cited by 132 · see citing works

The immunostimulatory nature of mRNA lipid nanoparticles

Sharma, P., Hoorn, D., Aitha, A., Breier, D., & Peer, D. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115175 · Cited by 132 · see citing works

Enhancing RNA-lipid nanoparticle delivery: Organ- and cell-specificity and barcoding strategies

Wei, P.-S., Thota, N., John, G., Chang, E., Lee, S., Wang, Y., Ma, Z., Tsai, Y.-H., & Mei, K. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.08.030 · Cited by 130 · see citing works

Aptamers: Cutting edge of cancer therapies

Shigdar, S. L., Schrand, B., Giangrande, P. H., & de Franciscis, V. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.06.010 · Cited by 128 · see citing works

mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy

Deng, Z., Tian, Y., Song, J., An, G., & Yang, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.887125 · Cited by 124 · see citing works

mRNA therapeutics deliver a hopeful message

Zhong, Z., Cafferty, S. M., Combes, F., Huysmans, H., Temmerman, J. D., Gitsels, A., Vanrompay, D. C. G., Catani, J. P., & Sanders, N. N. (2018) · Nano Today · doi:10.1016/j.nantod.2018.10.005 · Cited by 120 · see citing works

Ultrastructural Studies of Human Basophils and Mast Cells

Dvořàk, A. M. (2005) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5r6647.2005 · Cited by 118 · see citing works

Optimizing Cardiac Delivery of Modified mRNA

Sultana, N., Magadum, A., Hadas, Y., Kondrat, J., Singh, N., Youssef, E., Calderon, D., Chepurko, E., Dubois, N. C., Hajjar, R. J., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.016 · Cited by 114 · see citing works

Nanotechnology-empowered vaccine delivery for enhancing CD8+ T cells-mediated cellular immunity

Liu, G., Zhu, M., Zhao, X., & Nie, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113889 · Cited by 114 · see citing works

Evading innate immunity in nonviral mRNA delivery: don't shoot the messenger.

Devoldere, J., Dewitte, H., De Smedt, S. C., & Remaut, K. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.07.009 · Cited by 112 · see citing works

mRNA: Fulfilling the Promise of Gene Therapy

Weissman, D., & Karikó, K. (2015) · Molecular Therapy · doi:10.1038/mt.2015.138 · Cited by 111 · see citing works

From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape

Chakraborty, C., Sharma, A. R., Bhattacharya, M., & Lee, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.679344 · Cited by 111 · see citing works

Accelerated Blood Clearance of Lipid Nanoparticles Entails a Biphasic Humoral Response of B-1 Followed by B-2 Lymphocytes to Distinct Antigenic Moieties

Besin, G., Milton, J., Sabnis, S., Howell, R. D., Mihai, C., Burke, K. E., Benenato, K. E., Stanton, M., Smith, P., Senn, J. J., et al. (2019) · ImmunoHorizons · doi:10.4049/immunohorizons.1900029 · Cited by 108 · see citing works

Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases

Sahu, I., Haque, A. K. M. A., Weidensee, B., Weinmann, P., & Kormann, M. S. D. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.02.019 · Cited by 104 · see citing works

Exosome-Based Carrier for RNA Delivery: Progress and Challenges

Lu, Y., Huang, W. C., Li, M., & Zheng, A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020598 · Cited by 99 · see citing works

Personalized pancreatic cancer therapy: from the perspective of mRNA vaccine

Huang, X., Zhang, G., Tang, T., Gao, X., & Liang, T. (2022) · Military Medical Research · doi:10.1186/s40779-022-00416-w · Cited by 95 · see citing works

Engineering nanoparticle toolkits for mRNA delivery

Sun, B., Wu, W., Narasipura, E. A., Ma, Y., Yu, C., Fenton, O. S., & Song, H. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115042 · Cited by 93 · see citing works

Long-term gene therapy in the CNS: Reversal of hypothalamic diabetes insipidus in the Brattleboro rat by using an adenovirus expressing arginine vasopressin

Geddes, B. J., Harding, T. C., Lightman, S. L., & Uney, J. B. (1997) · Nature Medicine · doi:10.1038/nm1297-1402 · Cited by 92 · see citing works

mRNA: A Novel Avenue to Antibody Therapy?

Schlake, T., Thran, M., Fiedler, K., Heidenreich, R., Petsch, B., & Fotin‐Mleczek, M. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.03.002 · Cited by 90 · see citing works

Overexpression of urokinase receptor in mammalian cells following administration of the in vitro transcribed encoding mRNA

Karikó, K., Kuo, A., & Barnathan, E. S. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300930 · Cited by 89 · see citing works

Deliver the promise: RNAs as a new class of molecular entities for therapy and vaccination

Yu, A., & Tu, M. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107967 · Cited by 88 · see citing works

Lipid nanoparticle-based mRNA vaccines in cancers: Current advances and future prospects

Huang, T., Peng, L., Han, Y., Wang, D., He, X., Wang, J., & Ou, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.922301 · Cited by 84 · see citing works

Structurally Programmed Assembly of Translation Initiation Nanoplex for Superior mRNA Delivery

Li, J., Wang, W., He, Y., Li, Y., Yan, E. Z., Zhang, K., Irvine, D. J., & Hammond, P. T. (2017) · ACS Nano · doi:10.1021/acsnano.6b08447 · Cited by 82 · see citing works

Local Gene Expression in Axons and Nerve Endings: The Glia-Neuron Unit

Giuditta, A., Chun, J. T., Eyman, M., Cefaliello, C., Bruno, A. P., & Crispino, M. (2008) · Physiological Reviews · doi:10.1152/physrev.00051.2006 · Cited by 82 · see citing works

mRNA vaccines: the most recent clinical applications of synthetic mRNA

Kwon, S., Kwon, M., Im, S., Lee, K., & Lee, H. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01381-7 · Cited by 81 · see citing works

Nucleic acid therapeutics: Past, present, and future

Naeem, S., Zhang, J., Zhang, Y., & Wang, Y. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102440 · Cited by 78 · see citing works

Olfactory marker protein mRNA is found in axons of olfactory receptor neurons

Wensley, C., Stone, D., Baker, H. A., Kauer, J. S., Margolis, F. L., & Chikaraishi, D. M. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-07-04827.1995 · Cited by 78 · see citing works

Lipid Nanoparticles for Organ-Specific mRNA Therapeutic Delivery

Żak, M. M., & Zangi, L. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101675 · Cited by 75 · see citing works

mRNA – A game changer in regenerative medicine, cell-based therapy and reprogramming strategies

Chabanovska, O., Galow, A.-M., David, R., & Lemcke, H. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114002 · Cited by 76 · see citing works

Unlocking the Therapeutic Applicability of LNP-mRNA: Chemistry, Formulation, and Clinical Strategies

Huang, X., Ma, Y., Ma, G., & Xia, Y. (2024) · Research · doi:10.34133/research.0370 · Cited by 75 · see citing works

Size and Charge Characterization of Lipid Nanoparticles for mRNA Vaccines

Malburet, C., Leclercq, L., Cotte, J., Thiebaud, J., Bazin, E., Garinot, M., & Cottet, H. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.1c04778 · Cited by 71 · see citing works

The mRNA Vaccine Revolution: COVID-19 Has Launched the Future of Vaccinology

Ye, Z., Harmon, J., Ni, W., Li, Y., Wich, D., & Xu, Q. (2023) · ACS Nano · doi:10.1021/acsnano.2c12584 · Cited by 71 · see citing works

N1-methylpseudouridine found within COVID-19 mRNA vaccines produces faithful protein products

Kim, K. Q., Burgute, B. D., Tzeng, S., Jing, C., Jungers, C. F., Zhang, J., Yan, L. L., Vierstra, R. D., Djuranović, S., Evans, B. S., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111300 · Cited by 68 · see citing works

Expression and estrogen regulation of brain‐derived neurotrophic factor gene and protein in the forebrain of female prairie voles

Liu, Y., Fowler, C. D., Young, L. J., Yan, Q., Insel, T. R., & Wang, Z. (2001) · The Journal of Comparative Neurology · doi:10.1002/cne.1156 · Cited by 65 · see citing works

RNA in the axonal domain: a new dimension in neuronal functioning?

van Minnen, J. (1994) · The Histochemical Journal · doi:10.1007/bf00160050 · Cited by 64 · see citing works

ICV administration of anti-NPY antisense oligonucleotide: effects on feeding behavior, body weight, peptide content and peptide release

Hulsey, M. G., Pless, C. M., White, B. D., & Martin, R. J. (1995) · Regulatory Peptides · doi:10.1016/0167-0115(95)00110-w · Cited by 63 · see citing works

Impact of ionizable lipid type on the pharmacokinetics and biodistribution of mRNA-lipid nanoparticles after intravenous and subcutaneous injection

Ren, Y., Lin, L., Abdallah, M., Zhu, X., Liu, H., Fabb, S. A., Payne, T. J., Pouton, C. W., Johnston, A. P. R., & Trevaskis, N. L. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113945 · Cited by 61 · see citing works

Monkeypox virus: An emerging epidemic

Aljabali, A. A. A., Obeid, M. A., Nusair, M. B., Hmedat, A., & Tambuwala, M. M. (2022) · Microbial Pathogenesis · doi:10.1016/j.micpath.2022.105794 · Cited by 60 · see citing works

Adenovirus vectors enter the brain

Neve, R. L. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90174-k · Cited by 60 · see citing works

mRNA vaccines: a new era in vaccine development

Chandra, S., Wilson, J. C., Good, D. M., & Wei, M. Q. (2024) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2024.043987 · Cited by 58 · see citing works

Structural changes of anterior horn neurons and their synaptic input caudal to a low thoracic spinal cord hemisection in the adult rat: a light and electron microscopic study

Nacimiento, W., Sappok, T., Brook, G. A., T�th, L., Schoen, S. W., Noth, J., & Kreutzberg, G. W. (1995) · Acta Neuropathologica · doi:10.1007/bf00318567 · Cited by 55 · see citing works

mRNA vaccines in the context of cancer treatment: from concept to application

Fu, Q., Zhao, X., Hu, J., Jiao, Y., Yan, Y., Pan, X., Wang, X., & Jiao, F. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-024-06033-6 · Cited by 53 · see citing works

Neuronal expression of Fos protein in the hypothalamus of rats with heart failure

Patel, K. P., Zhang, K., Kenney, M., Weiss, M. L., & Mayhan, W. G. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02186-7 · Cited by 53 · see citing works

mRNA therapy at the convergence of genetics and nanomedicine

Conde, J., Langer, R., & Rueff, J. (2023) · Nature Nanotechnology · doi:10.1038/s41565-023-01347-w · Cited by 49 · see citing works

Messenger RNA-Based Therapeutics and Vaccines: What’s beyond COVID-19?

Li, D., Liu, C., Li, Y., Tenchov, R., Sasso, J. M., Zhang, D., Li, D., Zou, L., Wang, X., & Zhou, Q. A. (2023) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.3c00047 · Cited by 49 · see citing works

Complex Coacervates as a Promising Vehicle for mRNA Delivery: A Comprehensive Review of Recent Advances and Challenges

Forenzo, C., & Larsen, J. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00439 · Cited by 48 · see citing works

Revolutionizing Cancer Treatment: Unleashing the Power of Viral Vaccines, Monoclonal Antibodies, and Proteolysis-Targeting Chimeras in the New Era of Immunotherapy

Mohite, P. B., Yadav, V., Pandhare, R., Maitra, S., Saleh, F. M., Saleem, R. M., Al-malky, H. S., Kumarasamy, V., Subramaniyan, V., Abdel‐Daim, M. M., et al. (2024) · ACS Omega · doi:10.1021/acsomega.3c06501 · Cited by 47 · see citing works

The paths toward non-viral CAR-T cell manufacturing: A comprehensive review of state-of-the-art methods

Metanat, Y., Viktor, P., Amajd, A., Kaur, I., Hamed, A. M., Al-Abadi, N. K. A., Alwan, N. H., Chaitanya, M., Natrayan, L., Ghildiyal, P., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122683 · Cited by 48 · see citing works

Treatment of Intervertebral Disk Disease by the Administration of mRNA Encoding a Cartilage-Anabolic Transcription Factor

Lin, C., Crowley, S. T., Uchida, S., Komaki, Y., Kataoka, K., & Itaka, K. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.02.012 · Cited by 47 · see citing works

Expression of the Oxytocin and Vasopressin Genes

Young, W. S. (1992) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1992.tb00201.x · Cited by 47 · see citing works

Hybridization histochemical and immunohistochemical localization of inhibin/activin subunits and messenger ribonucleic acids in the rat brain

Roberts, V. J., Barth, S., Meunier, H., & Vale, W. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19960115)364:3 · Cited by 45 · see citing works

RNA Therapeutics: the Next Generation of Drugs for Cardiovascular Diseases

Bejar, N., Tat, T. T., & Kiss, D. (2022) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-01007-9 · Cited by 44 · see citing works

Mechanisms and research advances in mRNA antibody drug-mediated passive immunotherapy

Zhao, Y., Gan, L., Ke, D., Chen, Q., & Fu, Y. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04553-1 · Cited by 43 · see citing works

The Development of mRNA Vaccines for Infectious Diseases: Recent Updates

Nitika, Wei, J., & Hui, A. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s341694 · Cited by 42 · see citing works

Optimizing Modified mRNA In Vitro Synthesis Protocol for Heart Gene Therapy

Hadas, Y., Sultana, N., Youssef, E., Sharkar, M. T. K., Kaur, K., Chepurko, E., & Zangi, L. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2019.07.006 · Cited by 41 · see citing works

Delivery of synthetic mRNAs for tissue regeneration

Steinle, H., Weber, M., Stoppelkamp, S., Große‐Berkenbusch, K., Golombek, S., Weber, M., Çanak-Ipek, T., Trenz, S.-M., Schlensak, C., & Avci‐Adali, M. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114007 · Cited by 41 · see citing works

An mRNA vaccine to prevent genital herpes

Awasthi, S., & Friedman, H. M. (2021) · Translational research · doi:10.1016/j.trsl.2021.12.006 · Cited by 40 · see citing works

The messenger's great message for vaccination

Pascolo, S. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.1000871 · Cited by 40 · see citing works

Regulation of mRNA Transport and Translation in Axons

Vuppalanchi, D., Willis, D. E., & Twiss, J. L. (2009) · Results and problems in cell differentiation · doi:10.1007/400_2009_16 · Cited by 39 · see citing works

Differential compartmentalization of vasopressin messenger RNA and neuropeptide within the rat hypothalamo-neurohypophysial axonal tracts: Light and electron microscopic evidence

Trembleau, A., Morales, M., & Bloom, F. E. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00328-g · Cited by 38 · see citing works

Lipid-based colloidal nanoparticles for applications in targeted vaccine delivery

Khan, M. S., Appak‐Baskoy, S., Yang, C. J., Hong, J., Chae, J., Ha, H.-J., Lee, S., Tanaka, M., Choi, Y., & Choi, J. H. (2023) · Nanoscale Advances · doi:10.1039/d2na00795a · Cited by 37 · see citing works

Development of nucleic acid-based vaccines against dengue and other mosquito-borne flaviviruses: the past, present, and future

Bello, M. B., Alsaadi, A., Naeem, A., Almahboub, S. A., Bosaeed, M., & Aljedani, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1475886 · Cited by 37 · see citing works

RNA ‐based therapies for genodermatoses

Bornert, O., Peking, P., Bremer, J., Koller, U., van den Akker, P. C., Aartsma-Rus, A. M., Pasmooij, A. M. G., Murauer, E. M., & Nyström, A. (2016) · Experimental Dermatology · doi:10.1111/exd.13141 · Cited by 37 · see citing works

Reduction of exogenous vasopressin RNA poly(A) tail length increases its effectiveness in transiently correcting diabetes insipidus in the Brattleboro rat.

Maciejewski-Lenoir, D., Jirikowski, G. F., Sanna, P. P., & Bloom, F. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.4.1435 · Cited by 29 · see citing works

Vasopressin gene is expressed at low levels in the hypothalamus of the Brattleboro rat.

Majzoub, J. A., Pappey, A., Burg, R., & Habener, J. F. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.17.5296 · Cited by 47 · see citing works

Vasopressin Antisense Oligonucleotide Induces Temporary Diabetes Insipidus in Rats

Skutella, T., Probst, J. C., Engelmann, M., Wotjak, G. T., Landgraf, R., & Jirikowski, G. F. (1994) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1994.tb00561.x · Cited by 30 · see citing works

Defective regulation of vasopressin gene expression in Brattleboro rats

Majzoub, J. A., Carrazana, E. J., SHULMAN, J., Baker, K. J., & Emanuel, R. L. (1987) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1987.252.5.e637 · Cited by 24 · see citing works

In situ hybridization demonstrates vasopressin gene transcription in hypothalamic neurons of crossbred hypertensive × diabetes insipidus rats

McCabe, J. T., Almasan, K., Lehmann, E., ̈nze, J. H., Lang, R. E., Pfaff, D. W., & Ganten, D. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90226-6 · Cited by 11 · see citing works